- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01826942
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
March 25, 2014 updated by: Lumenis Be Ltd.
In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g.
face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation.
The investigators will also evaluate the effect of shallow fractional laser treatment versus deep parameters settings.
If effective treatments could be performed at time of surgery, this would result in both time and cost saving to the patient and to the healthcare system and will improve patient's self-image post surgeries.
Study Overview
Status
Terminated
Conditions
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Beverly Hills, California, United States, 90210
- Ronald L. Moy, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or Females
- At least 18 and no more than 65 years old
- The surgical area closure in these subjects should be at least 4cm
- Type of surgery scheduled:
Site 1: Surgical area closure on thin skin, including areas that require motion (e.g. face, hands, arms, thorax, etc.) Site 2: Surgical area closure on thick skin (abdominoplasty procedure)
- Willing to comply with study dosing and complete the entire course of the study
Exclusion Criteria:
- Active bacterial, fungal, or viral infection in the treatment area
- Active cold sores, or herpes in the treatment area
- Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning beds/booths and/or sunbathing) or expectations of tanning during the time of the study
- History of skin cancer, unless the surgical procedure of issue is for cancer treatment purposes.
- History of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis)
- Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche Dermatologics)
- History or presenting with a keloid scar
- Any current or recent treatment for cancer, unless the surgical procedure of issue is for cancer treatment purposes.
- Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study
- Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
- Subject planning any other cosmetic procedure to the study area during the study period, other than the treatments that will be performed by the investigator
- Female subject who is pregnant, nursing an infant or is less than 6 months after termination of breast feeding
- Small surgical closure (<4cm)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Thin skin
Single fractional CO2 treatment at surgical area closure procedure on thin skin
|
|
EXPERIMENTAL: Thick skin
Single fractional CO2 treatment at surgical area closure procedure on thick skin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Scar appearance by blinded evaluation of photographs of the three month follow-up visit
Time Frame: three month follow-up
|
three month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ACTUAL)
March 1, 2013
Study Completion (ACTUAL)
March 1, 2013
Study Registration Dates
First Submitted
April 4, 2013
First Submitted That Met QC Criteria
April 8, 2013
First Posted (ESTIMATE)
April 9, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 26, 2014
Last Update Submitted That Met QC Criteria
March 25, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUM-ABU-UP-13-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scar Prevention
-
Capstone TherapeuticsCompletedScar Prevention | Scar ReductionUnited States
-
PfizerCompletedScar PreventionUnited States
-
Thammasat University HospitalActive, not recruiting
-
PfizerCompleted
-
PfizerCompletedScar PreventionUnited States
-
Lemonex Inc.CompletedCicatrix | Scar PreventionKorea, Republic of
-
RXi Pharmaceuticals, Corp.CompletedCicatrix | Scar PreventionUnited States
-
RXi Pharmaceuticals, Corp.Completed
-
Capstone TherapeuticsCompletedScar Prevention | Scar ReductionUnited States
-
Hallym University Kangnam Sacred Heart HospitalRecruitingIntense Pulsed Light | Erbium-yttrium Aluminum Garnet Laser | Scar PreventionKorea, Republic of
Clinical Trials on Lumenis UltraPulse single fractional CO2 laser treatment thin skin
-
Massachusetts General HospitalActive, not recruitingChronic Radiation DermatitisUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Massachusetts General HospitalRecruitingBurn Scar | Hypertrophic ScarUnited States
-
Xijing HospitalCompletedVaginal AtrophyChina
-
University of CalgaryTerminated
-
Aarhus University HospitalBispebjerg HospitalUnknownAcne Scars - Mixed Atrophic and HypertrophicDenmark
-
Ulthera, IncCompletedScars | StriaeUnited States
-
Wake Forest University Health SciencesWithdrawn
-
Ahmed Hassan Nouh MDCompletedAlopecia AreataEgypt
-
Netherlands Institute for Pigment DisordersAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Completed